Timing of JAK initiation, shingles vaccine administration can affect outcomes in rheumatoid arthritis

For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation comparative to medication of recombinant zoster vaccine (RZV) tin impact aboriginal effect and arthritis control, according to a probe missive published online July 21 successful the Annals of Internal Medicine.